Acura Pharmaceuticals Inc (ACUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 410 | 1,351 | 1,091 | 1,220 | 1,324 |
| Gross Profit | 410 | 1,351 | 1,091 | 1,220 | 1,324 |
| Operating Expenses | 975 | 930 | 1,574 | 951 | 1,013 |
| Operating Income | -565 | 421 | -483 | 269 | 311 |
| Interest Expense | 113 | 113 | 112 | 114 | 111 |
| Pre-tax Income | -678 | 308 | -595 | 155 | 200 |
| Net Income Continuous | -678 | 308 | -595 | 155 | 200 |
| Net Income | $-678 | $308 | $-595 | $155 | $200 |
| EPS Basic Total Ops | -0.02 | 0.01 | -0.02 | 0.05 | 0.00 |
| EPS Basic Continuous Ops | -0.02 | 0.01 | -0.02 | 0.04 | 0.01 |
| EPS Diluted Total Ops | -0.02 | 0.01 | -0.02 | 0.05 | 0.00 |
| EPS Diluted Continuous Ops | -0.02 | 0.01 | -0.02 | 0.04 | 0.01 |
| EPS Diluted Before Non-Recurring Items | -0.02 | 0.01 | N/A | N/A | N/A |
| EBITDA(a) | $-545 | $441 | $-417 | $336 | $380 |